Drug information for ADDERALL 30
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
7.5MG;7.5MG;7.5MG;7.5MG
Discontinued
AMPHETAMINE ASPARTATE
;
AMPHETAMINE SULFATE
;
DEXTROAMPHETAMINE SACCHARATE
;
DEXTROAMPHETAMINE SULFATE
Amphetamine
TEVA WOMENS
11522
2007-06-14 Letter
2007-06-12 Label
2007-05-31 Other Important Information from FDA
2006-07-27 Label
2006-07-27 Label
2006-07-27 Letter
2006-07-27 Letter
2005-08-04 Label
2005-08-04 Label
2005-08-04 Letter
2005-08-04 Letter
2004-04-14 Review
2002-11-08 Letter
2000-06-12 Review
Drug Adverse Effects information for ADDERALL 30
Role code
Indications
Reaction
# Reports
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
PREMATURE EJACULATION
1
Ads by Google